FrançaisMovemberIn the News

In The News

Collaboration and Innovation in Prostate Cancer Research awarded with $5 Million in Movember Team Grants
Toronto, ON – June 11, 2013 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the inaugural Movember Team Grants. The program promotes collaboration between not only researchers but also institutions, providing a united approach to prostate cancer research. The recipient group will receive $5 million in funding. The 2013 Movember Team Grant has been awarded to Dr. Ralph Buttyan of the Vancouver Prostate Centre (Principal Investigator), who leads a team of 22 Co-Investigators. The title of their research is Tumour Cell Plasticity in Treatment-Resistant Prostate Cancer and their study will focus on targeting aggressive and lethal cancer.

Canadians Celebrate Father’s Day and the Men They Love
15 Communities Set to Increase Awareness of Prostate Cancer this Father’s Day TORONTO, ON – June 5, 2013 – Families across Canada will come together this Father’s Day, Sunday, June 16th, to celebrate the men they love at Prostate Cancer Canada’s Safeway Father’s Day Walk/Run. This annual event sponsored by Canada Safeway will see residents in 15 cities across the country lace up their running shoes to raise funds and awareness for prostate cancer. 

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


PSA Tests: The controversy continues

In our last entry we talked about some common concerns regarding PSA tests – sometimes even cancerous tumours are insignificant and don’t spread, and this means that PSA tests can lead to over diagnosis.

However, there’s another side to the PSA controversy. Sometimes PSA scores come back at normal levels, even when cancer is present.

Obviously this is problem. Like we mentioned last time, we realize the PSA test has its flaws. But still, this doesn’t strike us as a reason to not get tested. Sometimes prostate cancer can exist for years before it causes symptoms. Annual testing would most likely catch any changes before it progressed significantly.

This is one of the reasons though that we think the PSA test is best partnered with a DRE. DREs are digital rectal exams where your doctor can note any physical abnormalities.
Combined, the tests are the best screening tool we have to date.

It’s your health … so, why make excuses?

We recommend your first PSA test at age 40. While this is young to contract prostate cancer, we think it’s the best way to establish a base PSA score so that consecutive test results have something to be measured against.

Age 40 also normally precedes the natural growth of the prostate glands that coincides with the aging process. Since prostate growth influences PSA levels, getting a base PSA score before this starts to happen will let you measure the rate at which PSA increasing. Your doctor will be able to know if your PSA score increases are worrisome or not.

If there’s nothing on your medical record to go by, don’t you imagine it would be even more difficult for your doctor to screen you for prostate cancer?

Isn’t that what we’re all trying to avoid?

4/28/2009 9:55:32 AM
Twitter feed temporarily unavailable.
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325

Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital